Erika Elgstrand Wettergren - Publications
Affiliations: | Wallenberg Neuroscience Center, Lund University, Lund, Skåne län, Sweden |
Year | Citation | Score | |||
---|---|---|---|---|---|
2016 | Breger L, Wettergren EE, Quintino L, Lundberg C. Regulated Gene Therapy. Methods in Molecular Biology (Clifton, N.J.). 1382: 57-66. PMID 26611578 DOI: 10.1007/978-1-4939-3271-9_4 | 0.673 | |||
2014 | Wettergren EE, Quintino L, Lundberg C. Gene therapy using synthetic microRNA directed against GAD67 has beneficial effect on motor behaviour in 6-OHDA lesioned rats Journal of Gene Therapy Aspects. 1: 1. DOI: 10.7243/2057-164X-1-1 | 0.676 | |||
2014 | Wettergren EE, Quintino L, Manfré G, Lundberg C. Gene therapy for Parkinson’s disease Neuromethods. 82: 181-191. DOI: 10.1007/978-1-62703-610-8_10 | 0.731 | |||
2013 | Quintino L, Manfré G, Wettergren EE, Namislo A, Isaksson C, Lundberg C. Functional neuroprotection and efficient regulation of GDNF using destabilizing domains in a rodent model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 2169-80. PMID 23881415 DOI: 10.1038/Mt.2013.169 | 0.72 | |||
2013 | Ã…kerblom M, Sachdeva R, Quintino L, Wettergren EE, Chapman KZ, Manfre G, Lindvall O, Lundberg C, Jakobsson J. Visualization and genetic modification of resident brain microglia using lentiviral vectors regulated by microRNA-9. Nature Communications. 4: 1770. PMID 23612311 DOI: 10.1038/Ncomms2801 | 0.667 | |||
2012 | Wettergren EE, Gussing F, Quintino L, Lundberg C. Novel disease-specific promoters for use in gene therapy for Parkinson's disease. Neuroscience Letters. 530: 29-34. PMID 23063686 DOI: 10.1016/J.Neulet.2012.09.059 | 0.594 | |||
Show low-probability matches. |